MAS
60
5
HPE
71
7
COP
56
3
DE
65
5
NOC
63
2
URI
56
8
EMC
90
14
FTI
87
3
MAC
48
-3
PG
43
2
DOV
64
5
TRV
56
3
MA
53
2
GT
52
2
DLTR
62
4
FRT
48
5
BA
56
4
BDX
54
-6
XOM
64
5
CHD
58
2
MAS
60
5
HPE
71
7
COP
56
3
DE
65
5
NOC
63
2
URI
56
8
EMC
90
14
FTI
87
3
MAC
48
-3
PG
43
2
DOV
64
5
TRV
56
3
MA
53
2
GT
52
2
DLTR
62
4
FRT
48
5
BA
56
4
BDX
54
-6
XOM
64
5
CHD
58
2
Financhill
Back

State Street SPDR S&P Biotech ETF Stock Predictions

Size matters when it's your portfolio.

Invest now at $0.85/share
Buy
55

XBI
State Street SPDR S&P Biotech ETF

Last Price:
$125.50
Seasonality Move:
-2.09%

7 Day Trial

ALL ACCESS PASS

$ 7

1.5 Million Users. Zero Hype. Still Private.

*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com

State Street SPDR S&P Biotech ETF Stock Forecast

  • Over the next 52 weeks, State Street SPDR S&P Biotech ETF has on average historically risen by 14.6% based on the past 20 years of stock performance.
  • State Street SPDR S&P Biotech ETF has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
  • Is State Street SPDR S&P Biotech ETF Stock Undervalued?
    The current State Street SPDR S&P Biotech ETF [XBI] share price is $125.51. The Score for XBI is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • XBI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will State Street SPDR S&P Biotech ETF Stock Go Up Next Year?

  • Over the next 52 weeks, State Street SPDR S&P Biotech ETF has on average historically risen by 14.6% based on the past 20 years of stock performance.

State Street SPDR S&P Biotech ETF Stock Rating

Buy
55
State Street SPDR S&P Biotech ETF (XBI) is a Buy

Is State Street SPDR S&P Biotech ETF overpriced?

  • State Street SPDR S&P Biotech ETF has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%

State Street SPDR S&P Biotech ETF Stock Price History

Is XBI stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XBI is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
132.09
52-Week Low:
66.66

Prediction Charts

Market Cap:
0
Price in USD:
125.51
Volume:
9.6M
Beta:
0.96

Technical Analysis

SMA50:
124.01
SMA100:
115.38
SMA200:
100.26
52-Wk Change:
34.42%

Stock Predictions

  • Is State Street SPDR S&P Biotech ETF stock public?
    Yes, State Street SPDR S&P Biotech ETF is a publicly traded company.
  • What is the State Street SPDR S&P Biotech ETF stock quote today?
    The State Street SPDR S&P Biotech ETF stock price is 125.51 USD today.
  • How to buy State Street SPDR S&P Biotech ETF stock online?
    You can buy State Street SPDR S&P Biotech ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-20 122.42 125.29 125.41 121.27
Jan-21 125.22 128.18 128.29 124.89
Jan-22 128.28 131.57 132.09 128.19
Jan-23 130.93 128.04 131.67 127.86
Jan-26 126.81 127.86 128.49 125.91
Jan-27 127.87 128.53 129.93 127.53
Jan-28 128.61 125.94 128.71 125.80
Jan-29 125.93 126.74 127.35 125.41
Jan-30 126.17 124.75 127.14 123.79
Feb-2 124.05 127.35 127.55 124.03
Feb-3 127.29 127.65 129.70 125.98
Feb-4 127.87 125.29 128.32 123.41
Feb-5 124.23 120.72 126.62 120.28
Feb-6 122.85 125.51 125.87 122.79

State Street SPDR S&P Biotech ETF Earnings

Data Unavailable

State Street SPDR S&P Biotech ETF Forecast Revenue Growth

Data Unavailable

* State Street SPDR S&P Biotech ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.